These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38506227)

  • 41. scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells.
    Silveira MJ; Martins C; Cruz T; Castro F; Amorim-Costa Â; Chester K; Oliveira MJ; Sarmento B
    J Nanobiotechnology; 2023 Oct; 21(1):357. PubMed ID: 37784150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental model.
    Leconte A; Garambois V; Ychou M; Robert B; Pourquier D; Terskikh A; Mach JP; Pèlegrin A
    Br J Cancer; 1999 Jul; 80(9):1373-9. PubMed ID: 10424738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Targeting Colorectal Cancer Stem-Like Cells with Anti-CD133 Antibody-Conjugated SN-38 Nanoparticles.
    Ning ST; Lee SY; Wei MF; Peng CL; Lin SY; Tsai MH; Lee PC; Shih YH; Lin CY; Luo TY; Shieh MJ
    ACS Appl Mater Interfaces; 2016 Jul; 8(28):17793-804. PubMed ID: 27348241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer.
    Lwin TM; Minnix M; Li L; Sherman A; Hong T; Wong JYC; Olafsen T; Poku E; Bouvet M; Fong Y; Shively JE; Yazaki PJ
    Mol Imaging Biol; 2023 Aug; 25(4):727-734. PubMed ID: 37341873
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selection and characterisation of Affimers specific for CEA recognition.
    Shamsuddin SH; Jayne DG; Tomlinson DC; McPherson MJ; Millner PA
    Sci Rep; 2021 Jan; 11(1):744. PubMed ID: 33436840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preclinical evaluation of a novel CEA-targeting near-infrared fluorescent tracer delineating colorectal and pancreatic tumors.
    Boonstra MC; Tolner B; Schaafsma BE; Boogerd LS; Prevoo HA; Bhavsar G; Kuppen PJ; Sier CF; Bonsing BA; Frangioni JV; van de Velde CJ; Chester KA; Vahrmeijer AL
    Int J Cancer; 2015 Oct; 137(8):1910-20. PubMed ID: 25895046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy.
    Shirasu N; Yamada H; Shibaguchi H; Kuroki M; Kuroki M
    Int J Cancer; 2014 Dec; 135(11):2697-710. PubMed ID: 24740257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carcinoembryonic Antigen (CEA) and Hepatic Metastasis in Colorectal Cancer: Update on Biomarker for Clinical and Biotechnological Approaches.
    Campos-da-Paz M; Dórea JG; Galdino AS; Lacava ZGM; de Fatima Menezes Almeida Santos M
    Recent Pat Biotechnol; 2018; 12(4):269-279. PubMed ID: 30062978
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thionine-doped nanometer-sized silica conjugated with phenylboronic acid: An innovative recognition/signal element for voltammetric aptasensing of colorectal cancer-related carcinoembryonic antigen.
    Chi L; Xu C; Li S; Wang X; Tang D; Xue F
    Anal Chim Acta; 2020 Nov; 1136():91-98. PubMed ID: 33081954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Increased expression of CEA and MHC class I in colorectal cancer cell lines exposed to chemotherapy drugs.
    Ohtsukasa S; Okabe S; Yamashita H; Iwai T; Sugihara K
    J Cancer Res Clin Oncol; 2003 Dec; 129(12):719-26. PubMed ID: 14564514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors.
    Behr TM; Sharkey RM; Juweid MI; Dunn RM; Ying Z; Zhang CH; Siegel JA; Gold DV; Goldenberg DM
    Cancer Res; 1996 Apr; 56(8):1805-16. PubMed ID: 8620497
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Radioimmunodetection of colorectal cancer, using anti-CEA monoclonal antibodies].
    Murayama H; Watanabe T; Sakamoto J; Tadokoro M; Takagi H; Sakuma S
    Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1732-41. PubMed ID: 2594001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In Vivo Fluorescence Imaging of the Activity of CEA TCB, a Novel T-Cell Bispecific Antibody, Reveals Highly Specific Tumor Targeting and Fast Induction of T-Cell-Mediated Tumor Killing.
    Lehmann S; Perera R; Grimm HP; Sam J; Colombetti S; Fauti T; Fahrni L; Schaller T; Freimoser-Grundschober A; Zielonka J; Stoma S; Rudin M; Klein C; Umana P; Gerdes C; Bacac M
    Clin Cancer Res; 2016 Sep; 22(17):4417-27. PubMed ID: 27117182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer.
    Park JW; Chang HJ; Kim BC; Yeo HY; Kim DY
    Colorectal Dis; 2013 Sep; 15(9):e503-11. PubMed ID: 23711333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative characterization of the efficiency and cellular pharmacokinetics of Foscan- and Foslip-based photodynamic treatment in human biliary tract cancer cell lines.
    Kiesslich T; Berlanda J; Plaetzer K; Krammer B; Berr F
    Photochem Photobiol Sci; 2007 Jun; 6(6):619-27. PubMed ID: 17549263
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Uptake of radiolabeled anti-CEA antibodies in human colorectal primary tumors as a function of tumor mass.
    Williams LE; Bares RB; Fass J; Hauptmann S; Schumpelick V; Buell U
    Eur J Nucl Med; 1993 Apr; 20(4):345-7. PubMed ID: 8491228
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Imaging of Radiolabeled Bispecific T-Cell Engager
    Waaijer SJH; Warnders FJ; Stienen S; Friedrich M; Sternjak A; Cheung HK; van Scheltinga AGTT; Schröder CP; de Vries EGE; Lub-de Hooge MN
    Clin Cancer Res; 2018 Oct; 24(20):4988-4996. PubMed ID: 29980531
    [No Abstract]   [Full Text] [Related]  

  • 58. Advantage of a residualizing iodine radiolabel in the therapy of a colon cancer xenograft targeted with an anticarcinoembryonic antigen monoclonal antibody.
    Stein R; Govindan SV; Hayes M; Griffiths GL; Hansen HJ; Horak ID; Goldenberg DM
    Clin Cancer Res; 2005 Apr; 11(7):2727-34. PubMed ID: 15814655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Demonstration of monoclonal anti-carcinoembryonic antigen (CEA) antibody internalization by electron microscopy, western blotting and radioimmunoassay.
    Tsaltas G; Ford CH; Gallant M
    Anticancer Res; 1992; 12(6B):2133-42. PubMed ID: 1295459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas.
    Oberst MD; Fuhrmann S; Mulgrew K; Amann M; Cheng L; Lutterbuese P; Richman L; Coats S; Baeuerle PA; Hammond SA
    MAbs; 2014; 6(6):1571-84. PubMed ID: 25484061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.